Efficacy and safety of edaravone dexborneol in acute large vessel occlusion patients with successful recanalization after endovascular treatment

Background and purpose: Edaravone dexborneol (ED) is a novel cytoprotective drug for treating acute ischemic stroke (AIS) with synergistic antioxidant and anti-inflammatory effects. This study aimed to assess the efficacy and safety of ED in acute large vessel occlusion (LVO) patients with successfu...

Повний опис

Бібліографічні деталі

Автори:	Xiangliang Chen, Liyuan Wang, Yunyun Xiong, Zhenqiang Zhao, Kailai Huang, Zhenhui Duan, Kangmeng Wang, Chunhua Yun, Meipin Yang, Tianyi Xu, Wenhua Liu, Wei Li
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Elsevier 2025-12-01
Серія:	Journal of Stroke and Cerebrovascular Diseases
Предмети:	Edaravone dexborneol Endovascular treatment Large vessel occlusion Acute ischemic stroke
Онлайн доступ:	http://www.sciencedirect.com/science/article/pii/S1052305725002824
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!